Banks - Regional
Compare Stocks
4 / 10Stock Comparison
CARE vs NTRS vs STT vs NBTB
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Banks - Regional
CARE vs NTRS vs STT vs NBTB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Banks - Regional | Asset Management | Asset Management | Banks - Regional |
| Market Cap | $580M | $29.66B | $41.99B | $2.35B |
| Revenue (TTM) | $255M | $14.30B | $21.97B | $867M |
| Net Income (TTM) | $31M | $1.74B | $2.98B | $169M |
| Gross Margin | 61.7% | 56.5% | 58.5% | 72.1% |
| Operating Margin | 15.7% | 16.3% | 15.5% | 25.3% |
| Forward P/E | 4.8x | 14.8x | 12.0x | 10.8x |
| Total Debt | $179M | $16.43B | $36.79B | $327M |
| Cash & Equiv. | $105M | $61.13B | $116.10B | $185M |
CARE vs NTRS vs STT vs NBTB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Carter Bankshares, … (CARE) | 100 | 371.0 | +271.0% |
| Northern Trust Corp… (NTRS) | 100 | 202.5 | +102.5% |
| State Street Corpor… (STT) | 100 | 244.1 | +144.1% |
| NBT Bancorp Inc. (NBTB) | 100 | 143.9 | +43.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CARE vs NTRS vs STT vs NBTB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CARE carries the broadest edge in this set and is the clearest fit for sleep-well-at-night.
- Lower volatility, beta 0.56, Low D/E 42.5%, current ratio 0.75x
- Lower P/E (4.8x vs 10.8x)
- Beta 0.56 vs STT's 1.19, lower leverage
- +69.0% vs NBTB's +9.0%
NTRS is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- Efficiency ratio 0.4% vs NBTB's 0.5% (lower = leaner)
- Efficiency ratio 0.4% vs NBTB's 0.5%
STT is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 19.6%, EPS growth 47.1%
- 186.8% 10Y total return vs CARE's 112.9%
- PEG 1.36 vs NBTB's 1.53
- 19.6% NII/revenue growth vs NTRS's -9.9%
NBTB is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 12 yrs, beta 0.89, yield 3.2%
- Beta 0.89, yield 3.2%, current ratio 1.60x
- NIM 3.1% vs STT's 0.8%
- 3.2% yield, 12-year raise streak, vs STT's 2.3%, (1 stock pays no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.6% NII/revenue growth vs NTRS's -9.9% | |
| Value | Lower P/E (4.8x vs 10.8x) | |
| Quality / Margins | Efficiency ratio 0.4% vs NBTB's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.56 vs STT's 1.19, lower leverage | |
| Dividends | 3.2% yield, 12-year raise streak, vs STT's 2.3%, (1 stock pays no dividend) | |
| Momentum (1Y) | +69.0% vs NBTB's +9.0% | |
| Efficiency (ROA) | Efficiency ratio 0.4% vs NBTB's 0.5% |
CARE vs NTRS vs STT vs NBTB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CARE vs NTRS vs STT vs NBTB — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NBTB leads in 3 of 6 categories
CARE leads 2 • NTRS leads 0 • STT leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NBTB leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
STT is the larger business by revenue, generating $22.0B annually — 86.3x CARE's $255M. NBTB is the more profitable business, keeping 19.5% of every revenue dollar as net income compared to NTRS's 12.1%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $255M | $14.3B | $22.0B | $867M |
| EBITDAEarnings before interest/tax | $46M | $3.2B | $4.3B | $241M |
| Net IncomeAfter-tax profit | $31M | $1.7B | $3.0B | $169M |
| Free Cash FlowCash after capex | $30M | $4.7B | -$6.1B | $225M |
| Gross MarginGross profit ÷ Revenue | +61.7% | +56.5% | +58.5% | +72.1% |
| Operating MarginEBIT ÷ Revenue | +15.7% | +16.3% | +15.5% | +25.3% |
| Net MarginNet income ÷ Revenue | +12.3% | +12.1% | +12.2% | +19.5% |
| FCF MarginFCF ÷ Revenue | +12.5% | +38.2% | -64.3% | +25.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +8.3% | +7.1% | +23.0% | +39.5% |
Valuation Metrics
Evenly matched — NTRS and STT and NBTB each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 13.5x trailing earnings, NBTB trades at a 28% valuation discount to CARE's 18.7x P/E. Adjusting for growth (PEG ratio), NTRS offers better value at 1.86x vs STT's 2.05x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $580M | $29.7B | $42.0B | $2.4B |
| Enterprise ValueMkt cap + debt − cash | $654M | -$15.0B | -$37.3B | $2.5B |
| Trailing P/EPrice ÷ TTM EPS | 18.71x | 18.31x | 18.12x | 13.53x |
| Forward P/EPrice ÷ next-FY EPS est. | 4.77x | 14.80x | 11.99x | 10.80x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.86x | 2.05x | 1.92x |
| EV / EBITDAEnterprise value multiple | 16.34x | -4.68x | -9.33x | 10.35x |
| Price / SalesMarket cap ÷ Revenue | 2.28x | 2.07x | 1.91x | 2.71x |
| Price / BookPrice ÷ Book value/share | 1.40x | 2.33x | 1.78x | 1.21x |
| Price / FCFMarket cap ÷ FCF | 18.25x | 5.43x | — | 10.75x |
Profitability & Efficiency
NBTB leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
NTRS delivers a 13.4% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $8 for CARE. NBTB carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to STT's 1.45x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs STT's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +7.6% | +13.4% | +10.8% | +9.5% |
| ROA (TTM)Return on assets | +0.7% | +1.0% | +0.8% | +1.1% |
| ROICReturn on invested capital | +5.7% | +6.0% | +4.6% | +7.9% |
| ROCEReturn on capital employed | +1.5% | +9.0% | +4.6% | +2.4% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 6 | 4 | 7 |
| Debt / EquityFinancial leverage | 0.43x | 1.27x | 1.45x | 0.17x |
| Net DebtTotal debt minus cash | $73M | -$44.7B | -$79.3B | $142M |
| Cash & Equiv.Liquid assets | $105M | $61.1B | $116.1B | $185M |
| Total DebtShort + long-term debt | $179M | $16.4B | $36.8B | $327M |
| Interest CoverageEBIT ÷ Interest expense | 0.39x | 0.38x | 0.42x | 1.05x |
Total Returns (Dividends Reinvested)
CARE leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CARE five years ago would be worth $18,721 today (with dividends reinvested), compared to $12,989 for NBTB. Over the past 12 months, CARE leads with a +69.0% total return vs NBTB's +9.0%. The 3-year compound annual growth rate (CAGR) favors NTRS at 32.3% vs NBTB's 15.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +34.8% | +15.5% | +16.6% | +9.3% |
| 1-Year ReturnPast 12 months | +69.0% | +66.6% | +66.2% | +9.0% |
| 3-Year ReturnCumulative with dividends | +94.7% | +131.7% | +128.4% | +54.1% |
| 5-Year ReturnCumulative with dividends | +87.2% | +46.7% | +86.2% | +29.9% |
| 10-Year ReturnCumulative with dividends | +112.9% | +170.2% | +186.8% | +102.2% |
| CAGR (3Y)Annualised 3-year return | +24.9% | +32.3% | +31.7% | +15.5% |
Risk & Volatility
CARE leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CARE is the less volatile stock with a 0.56 beta — it tends to amplify market swings less than STT's 1.19 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CARE currently trades 98.5% from its 52-week high vs NTRS's 92.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.56x | 1.14x | 1.19x | 0.89x |
| 52-Week HighHighest price in past year | $26.58 | $173.19 | $156.18 | $46.92 |
| 52-Week LowLowest price in past year | $15.37 | $97.00 | $90.94 | $39.20 |
| % of 52W HighCurrent price vs 52-week peak | +98.5% | +92.4% | +95.3% | +96.1% |
| RSI (14)Momentum oscillator 0–100 | 75.4 | 59.4 | 63.9 | 57.3 |
| Avg Volume (50D)Average daily shares traded | 276K | 1.1M | 2.0M | 236K |
Analyst Outlook
NBTB leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CARE as "Buy", NTRS as "Hold", STT as "Buy", NBTB as "Hold". Consensus price targets imply 7.8% upside for STT (target: $160) vs -3.9% for NTRS (target: $154). For income investors, NBTB offers the higher dividend yield at 3.17% vs NTRS's 1.96%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $27.00 | $153.75 | $160.44 | $46.00 |
| # AnalystsCovering analysts | 4 | 35 | 37 | 10 |
| Dividend YieldAnnual dividend ÷ price | — | +2.0% | +2.3% | +3.2% |
| Dividend StreakConsecutive years of raises | 0 | 1 | 3 | 12 |
| Dividend / ShareAnnual DPS | — | $3.14 | $3.42 | $1.43 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.4% | +4.3% | +6.9% | +0.4% |
NBTB leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CARE leads in 2 (Total Returns, Risk & Volatility). 1 tied.
CARE vs NTRS vs STT vs NBTB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CARE or NTRS or STT or NBTB a better buy right now?
For growth investors, State Street Corporation (STT) is the stronger pick with 19.
6% revenue growth year-over-year, versus -9. 9% for Northern Trust Corporation (NTRS). NBT Bancorp Inc. (NBTB) offers the better valuation at 13. 5x trailing P/E (10. 8x forward), making it the more compelling value choice. Analysts rate Carter Bankshares, Inc. (CARE) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CARE or NTRS or STT or NBTB?
On trailing P/E, NBT Bancorp Inc.
(NBTB) is the cheapest at 13. 5x versus Carter Bankshares, Inc. at 18. 7x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 4. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: State Street Corporation wins at 1. 36x versus NBT Bancorp Inc. 's 1. 53x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — CARE or NTRS or STT or NBTB?
Over the past 5 years, Carter Bankshares, Inc.
(CARE) delivered a total return of +87. 2%, compared to +29. 9% for NBT Bancorp Inc. (NBTB). Over 10 years, the gap is even starker: STT returned +186. 8% versus NBTB's +102. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CARE or NTRS or STT or NBTB?
By beta (market sensitivity over 5 years), Carter Bankshares, Inc.
(CARE) is the lower-risk stock at 0. 56β versus State Street Corporation's 1. 19β — meaning STT is approximately 110% more volatile than CARE relative to the S&P 500. On balance sheet safety, NBT Bancorp Inc. (NBTB) carries a lower debt/equity ratio of 17% versus 145% for State Street Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — CARE or NTRS or STT or NBTB?
By revenue growth (latest reported year), State Street Corporation (STT) is pulling ahead at 19.
6% versus -9. 9% for Northern Trust Corporation (NTRS). On earnings-per-share growth, the picture is similar: State Street Corporation grew EPS 47. 1% year-over-year, compared to -10. 5% for Northern Trust Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CARE or NTRS or STT or NBTB?
NBT Bancorp Inc.
(NBTB) is the more profitable company, earning 19. 5% net margin versus 12. 1% for Northern Trust Corporation — meaning it keeps 19. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NBTB leads at 25. 3% versus 15. 5% for STT. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CARE or NTRS or STT or NBTB more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, State Street Corporation (STT) is the more undervalued stock at a PEG of 1. 36x versus NBT Bancorp Inc. 's 1. 53x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Carter Bankshares, Inc. (CARE) trades at 4. 8x forward P/E versus 14. 8x for Northern Trust Corporation — 10. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for STT: 7. 8% to $160. 44.
08Which pays a better dividend — CARE or NTRS or STT or NBTB?
In this comparison, NBTB (3.
2% yield), STT (2. 3% yield), NTRS (2. 0% yield) pay a dividend. CARE does not pay a meaningful dividend and should not be held primarily for income.
09Is CARE or NTRS or STT or NBTB better for a retirement portfolio?
For long-horizon retirement investors, NBT Bancorp Inc.
(NBTB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 89), 3. 2% yield, +102. 2% 10Y return). Both have compounded well over 10 years (NBTB: +102. 2%, STT: +186. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CARE and NTRS and STT and NBTB?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CARE is a small-cap quality compounder stock; NTRS is a mid-cap quality compounder stock; STT is a mid-cap high-growth stock; NBTB is a small-cap deep-value stock. NTRS, STT, NBTB pay a dividend while CARE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.